======= SOX2 ======= == Gene Information == * **Official Symbol**: SOX2 * **Official Name**: SRY-box transcription factor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6657|6657]] * **UniProt**: [[https://www.uniprot.org/uniprot/P48431|P48431]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SOX2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SOX2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/184429|Open OMIM]] == Function Summary == * **Entrez Summary**: This intronless gene encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The product of this gene is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. Mutations in this gene have been associated with optic nerve hypoplasia and with syndromic microphthalmia, a severe form of structural eye malformation. This gene lies within an intron of another gene called SOX2 overlapping transcript (SOX2OT). [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (By similarity). Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (By similarity). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). {ECO:0000250, ECO:0000269|PubMed:18035408}. |HMG box| |SOXp| |endodermal cell fate specification| |endodermal cell fate commitment| |adenohypophysis development| |glial cell fate commitment| |neuronal stem cell population maintenance| |nuclear transcription factor complex| |cell fate commitment involved in formation of primary germ layer| |miRNA binding| |endodermal cell differentiation| |pituitary gland development| |endoderm formation| |tissue regeneration| |somatic stem cell population maintenance| |endoderm development| |diencephalon development| |transcription regulatory region sequence-specific DNA binding| |cell fate specification| |formation of primary germ layer| |endocrine system development| |negative regulation of epithelial cell proliferation| |osteoblast differentiation| |stem cell population maintenance| |maintenance of cell number| |cell cycle arrest| |regeneration| |gastrulation| |glial cell differentiation| |negative regulation of canonical Wnt signaling pathway| |inner ear development| |transcription factor complex| |negative regulation of Wnt signaling pathway| |gliogenesis| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |transcription regulatory region DNA binding| |ear development| |negative regulation of neuron differentiation| |regulation of cysteine-type endopeptidase activity| |cell fate commitment| |positive regulation of cell-cell adhesion| |ossification| |regulation of canonical Wnt signaling pathway| |negative regulation of neurogenesis| |negative regulation of nervous system development| |negative regulation of cell development| |regulation of epithelial cell proliferation| |eye development| |regulation of Wnt signaling pathway| |visual system development| |sensory system development| |forebrain development| |developmental growth| |growth| |regulation of cell-cell adhesion| |positive regulation of cell adhesion| |gland development| |regulation of endopeptidase activity| |sequence-specific DNA binding| |regulation of peptidase activity| |DNA-binding transcription activator activity, RNA polymerase II-specific| |wound healing| |response to growth factor| |positive regulation of MAPK cascade| |sensory organ development| |embryonic morphogenesis| |response to wounding| |negative regulation of cell cycle| |regulation of neuron differentiation| |cytokine-mediated signaling pathway| |negative regulation of cell population proliferation| |DNA-binding transcription factor activity| |regulation of cell adhesion| |chromatin organization| |negative regulation of cell differentiation| |regulation of proteolysis| |brain development| |regulation of MAPK cascade| |head development| |regulation of neurogenesis| |negative regulation of transcription by RNA polymerase II| |anatomical structure formation involved in morphogenesis| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |positive regulation of cell differentiation| |embryo development| |central nervous system development| |cell cycle process| |cellular response to cytokine stimulus| |neuron differentiation| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |chromosome organization| |response to cytokine| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |positive regulation of protein modification process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |regulation of hydrolase activity| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |generation of neurons| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |regulation of cell death| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 6/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|3/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12441 * **Expression level (log2 read counts)**: -2.08 {{:chemogenomics:nalm6 dist.png?nolink |}}